Acumen Pharmaceuticals, Inc.

ABOS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.2B · 61 employees
84
SEC Filings
$2.92
Close 2026-09-11
61
Employees

Business Summary

Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing disease-modifying treatments for Alzheimer's disease (AD). Its lead candidate, sabirnetug (ACU193), is a humanized IgG2 monoclonal antibody selectively targeting soluble amyloid-beta oligomers (AOs). Sabirnetug is currently in the Phase 2 ALTITUDE-AD trial. The company also develops an Enhanced Brain Delivery (EBD) AO-targeted therapy and a subcutaneous sabirnetug formulation in collaboration with Halozyme.

Latest Stock Quote

ABOS 2026-09-11 $2.92 O:$2.93 H:$2.985 L:$2.84 Vol:0.3M VWAP:$2.9055
origin leaf: null

Next Earnings

expected 2026-11-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001628280-26-021413EDGAR84K words
2025-03-272024-12-310001576885-25-000049EDGAR82K words
2024-03-262023-12-310001576885-24-000047EDGAR81K words
2023-03-272022-12-310001576885-23-000017EDGAR85K words
2022-03-282021-12-310001193125-22-086775EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001628280-26-056199EDGAR21K words
2025-11-122025-09-300001576885-25-000104EDGAR19K words
2025-08-122025-06-300001576885-25-000093EDGAR19K words
2025-05-132025-03-310001576885-25-000065EDGAR17K words
2024-11-122024-09-300001576885-24-000098EDGAR18K words
2024-08-132024-06-300001576885-24-000092EDGAR18K words
2024-05-142024-03-310001576885-24-000064EDGAR17K words
2023-11-132023-09-300001576885-23-000062EDGAR19K words
2023-08-082023-06-300001576885-23-000050EDGAR18K words
2023-05-092023-03-310001576885-23-000025EDGAR15K words
2022-11-142022-09-300001193125-22-284583EDGAR—
2022-08-152022-06-300001193125-22-221297EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-160001628280-26-062137EDGAR6K words
2026-08-120001628280-26-055940EDGAR3K words
2026-03-260001628280-26-021189EDGAR3K words
2026-03-160001628280-26-017885EDGAR2K words
2026-01-120001628280-26-001774EDGAR6K words
2025-11-120001576885-25-000102EDGAR3K words
2025-11-100001628280-25-050800EDGAR1K words
2025-08-120001576885-25-000091EDGAR3K words
2025-07-150001576885-25-000087EDGAR5K words
2025-06-050001576885-25-000072EDGAR1K words

84 total filings indexed. 57 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

alzheimer's-disease-treatment neurodegenerative-disease-therapeutics clinical-stage-biopharmaceuticals integrated-alzheimer's-disease-rating-scale-(iadrs) amyloid-related-imaging-abnormalities-(aria)-mri-assessment positron-emission-tomography-(pet)-centiloid-measurement arterial-spin-labeling-(asl)-mri surface-plasmon-resonance-(spr) elisa-assay

Company Identity

CIK0001576885
TickerABOS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.acumenpharm.com
Listed2021-07-01

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: fcc17e800f8533f32cd13d81285df0e1a8bb382d8df14f25bae617fc48489637
parent: ec82d81851b920399c2bce3c178fd5352d4ba6f7372e9f0003dc60dcd97cd5eb
content hash: 8cbd860a4678ef40fe8094e0f0f3e2179786354379e94dcd3a06a57e015f03dc
signed: 2026-09-29T12:00:06.263Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ABOS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ABOS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ABOS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.